BWX Technologies, Inc. (BWXT) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary presents a mixed picture. While there are positive elements such as strong growth in the Medical segment and unique positioning in TRISO fuel production, there are concerns about delivery risks in nuclear projects and high CapEx. The Q&A section highlights uncertainties, such as unclear timelines for key projects and potential delivery risks, which could weigh on investor sentiment. Without a clear market cap, it's challenging to gauge the exact impact, but the presence of both positive and negative factors suggests a neutral stock price movement.
Key Financial Performance
Revenue Revenue grew 26% year-over-year, with 11% of the growth being organic. The increase was driven by improved throughput, favorable pacing of work, and exceptional operational execution across business lines.
Adjusted EBITDA Adjusted EBITDA grew 14% year-over-year. This growth was attributed to robust performance in commercial operations and modestly higher Government Operations, partially offset by higher corporate expenses.
Earnings Per Share (EPS) Earnings per share grew 22% year-over-year. The increase was due to strong operating performance and approximately $0.08 of higher non-operating contributions.
Backlog Backlog ended at $8.7 billion, up 77% year-over-year and 19% sequentially. The increase was supported by robust bookings in government and consistent backlog in commercial operations.
Government Operations Revenue Government Operations revenue increased by 4% year-over-year. Growth was driven by strong bookings, including $1.4 billion from the second portion of the pricing agreement for Naval reactors and long lead material procurement contracts.
Government Operations Adjusted EBITDA Adjusted EBITDA for Government Operations grew 1% year-over-year. The growth was supported by operational efficiencies in naval propulsion plants and timing of technical services income.
Commercial Operations Revenue Commercial Operations revenue increased by 121% year-over-year, including 39% organic growth. The growth was driven by increases in commercial power and medical sectors, as well as contributions from Kinectrics.
Commercial Operations Adjusted EBITDA Adjusted EBITDA for Commercial Operations grew 162% year-over-year. The growth was attributed to higher sales, strong execution, and contributions from Kinectrics.
Free Cash Flow Free cash flow was $50 million for the quarter, reflecting solid earnings and effective working capital management.
Capital Expenditures Capital expenditures were $43 million for the quarter. The company expects full-year capital expenditures to be around 6% of sales, with potential increases in future periods for targeted growth investments.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Acquisition of Precision Components Group (PCG): BWXT acquired PCG, a U.S.-based manufacturer of complex heat transfer components for naval and commercial nuclear markets. This acquisition marks the first step in building domestic U.S. commercial nuclear manufacturing capacity.
Expansion of U.S. Manufacturing: Plans to establish a greenfield plant in Mount Vernon, Indiana, to produce larger heavy nuclear equipment, including steam generators and reactor pressure vessels.
Microreactors and Advanced Nuclear Fuels: Strong demand for TRISO fuel for demonstration reactors and future commercial projects. Collaboration with Kairos on TRISO fuel for Hermes 2 reactor for Google.
Commercial Nuclear Power Demand: Accelerating demand across the U.S., Canada, and Europe. BWXT is positioning itself to meet this demand with localized manufacturing capacity.
SMR and Large Reactor Projects: BWXT is the reactor vessel supplier for the first GE Hitachi BWRX-300 SMR in Canada, positioning itself competitively for future projects in the U.S. and Japan.
Entry into Nuclear Fusion Market: Kinectrics selected as the design and fabrication partner for the U.K. Tritium loop facility, marking an entry into the nuclear fusion market.
Operational Efficiencies in Naval Propulsion: Driving efficiencies in plants, contributing to good margin performance. Continued revenue growth expected with steady production of Virginia-class, Columbia-class, and Ford-class ship sets.
Improved Throughput and Reduced Lead Times: Accelerated throughput and reduced lead times in commercial operations, contributing to strong performance.
Strategic Investments in Growth: Investments in U.S. commercial nuclear manufacturing capacity and advanced nuclear and fuel capabilities to capture significant business opportunities.
Focus on Defense and Commercial Nuclear Markets: Positioning as a leader across the nuclear value chain in defense and commercial markets, enabling broad competitive outcomes.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Localized Manufacturing Capacity: The establishment of a U.S. commercial manufacturing footprint to complement Canadian operations is a strategic priority. However, this expansion involves risks related to execution, cost management, and integration of the newly acquired Precision Components Group (PCG).
Expansion of U.S. Commercial Manufacturing: Plans to build a greenfield plant in Mount Vernon, Indiana, and expand U.S. commercial nuclear manufacturing capacity carry risks of cost overruns, delays, and challenges in scaling operations to meet demand.
Regulatory Approvals: Engagement with the NRC for building an HEU enrichment facility in Tennessee involves regulatory risks, including potential delays or non-approval, which could impact project timelines and costs.
Supply Chain Organization: Organizing the supply chain for the new HPDU facility in Tennessee presents challenges, including potential disruptions, cost increases, and delays in construction and commissioning.
Market Demand for Advanced Nuclear Fuels: While demand for TRISO fuel and microreactors is strong, there is a risk of over-reliance on emerging markets that may face delays or funding challenges.
Capital Expenditures: Planned capital expenditures of 6% of sales, with potential for exceeding this level in future periods, could strain financial resources and impact profitability if not carefully managed.
Integration of Acquisitions: The integration of Kinectrics and PCG into existing operations poses risks related to cultural alignment, operational synergies, and achieving expected financial performance.
Economic and Geopolitical Factors: Economic uncertainties and geopolitical tensions could impact demand for nuclear components and services, particularly in international markets.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: BWXT expects revenue of at least $3.75 billion in 2026, representing high teens growth compared to 2025. Government Operations is expected to grow in the low teens, while Commercial Operations is projected to grow approximately 30%.
Adjusted EBITDA: The company has increased its adjusted EBITDA guidance to a range of $650 million to $665 million for 2026, with about 55% of full-year EBITDA anticipated in the second half.
Earnings Per Share (EPS): Non-GAAP EPS guidance for 2026 is set at $4.60 to $4.75, reflecting higher operating earnings.
Free Cash Flow: Free cash flow is expected to range between $315 million and $330 million in 2026, inclusive of mid- to high-teens operating cash flow growth.
Capital Expenditures: Capital expenditures for 2026 are expected to be around 6% of sales, with potential for higher levels in future periods to support growth investments in U.S. commercial nuclear manufacturing and advanced nuclear capabilities.
Commercial Nuclear Manufacturing Expansion: BWXT plans to expand its U.S. commercial nuclear manufacturing footprint, including a potential greenfield plant in Mount Vernon, Indiana, to produce larger heavy nuclear equipment. This expansion aims to meet rising demand for SMR and large reactor projects.
Defense Fuels Enrichment and HPDU Programs: The company is progressing on defense fuels enrichment and HPDU programs, with construction of a new facility in Jonesborough, Tennessee, expected to ramp through 2026 and continue over several years before transitioning to commissioning and production.
Microreactors and Advanced Nuclear Fuels: BWXT sees strong demand in land-based defense, commercial, and space markets for microreactors and advanced nuclear fuels, including TRISO fuel for demonstration reactors and future commercial projects.
Commercial Power Growth: Commercial power is expected to grow in the low teens in 2026, supported by backlog growth and new nuclear build projects, including SMRs in the U.S. and Canada.
Kinectrics Contribution: Kinectrics is expected to continue outperforming expectations, contributing to commercial operations growth and entering new markets such as nuclear fusion.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:How much is the company planning to pay for PCG, and what is the purpose of the acquisition?
A:The company plans to pay roughly $200 million for PCG. The acquisition is aimed at building out the company's footprint, focusing on manufacturing certain aspects, increasing capacity, and leveraging the workforce. However, it will not handle large-scale components, and additional facilities may be needed for heavier components.
Q:What opportunities does the company see in the space end market?
A:The company sees opportunities in civil space, including nuclear electric propulsion, efficient surface power for lunar bases, and nuclear thermal propulsion. They also see more fertile opportunities in national security space, particularly in power and propulsion.
Q:Will the new commercial facility have any limitations regarding components it can build for customers?
A:No, the new commercial facility will not have limitations. It will focus on creating centers of excellence for specific components like reactor internals, tanks, pressurizers, steam generators, and reactor pressure vessels, serving multiple customers and platforms.
Q:Does the PCG acquisition have any positive effects on the naval business?
A:Yes, the acquisition brings an existential qualified nuclear workforce, additional capacity, and rare nuclear manufacturing credentials. These capabilities are beneficial for both the naval and commercial businesses.
Q:How much capacity does the company plan to add in the U.S., and what is the estimated capital needed?
A:The company is expanding its Cambridge plant by 60,000 square feet and plans to add 100,000 square feet in Mount Vernon. The Mount Vernon facility will be more expensive than the Cambridge build-out, roughly twice the cost.
Q:Is the company considering customer funding for commercial capacity growth?
A:No, the company has the balance sheet to fund its capacity growth needs.
Q:What initiatives are in place to improve throughput?
A:The company has formal initiatives called Driving Performance Excellence (DPX) focused on operational excellence. They are working on dedicated throughput projects in areas like Pickering steam generators and TheraSphere to increase capacity.
Q:Why did the company not pursue recent ANPI awards?
A:The company did not pursue the ANPI awards because they were focused on smaller-scale reactors with lower power output, which did not align with their transportable Pele reactor or BANR reactor initiatives.
Q:What is the company's competitive positioning in TRISO fuel production?
A:The company is the only producer of TRISO fuel at scale, producing hundreds of kilograms annually. They are considering brownfield and greenfield opportunities to scale production and reduce costs, positioning themselves as a key player in the market.
Q:When could awards related to the Japan $40 billion GE Hitachi project be added to the backlog?
A:Awards could potentially be added to the backlog this year, but there are still hurdles to clear.
Q:How long will it take to operationalize the Mount Vernon commercial expansion, and how important is it for winning U.S.-based business?
A:The Mount Vernon expansion will take 2-3 years to complete. Having U.S. industrial capacity is important for winning U.S.-based business, especially government projects.
Q:What is the company's progress on the Centrifuge Manufacturing Facility and NRC licensing?
A:The company is progressing on the Centrifuge Manufacturing Facility, working on prototypes, and expects NRC licensing for HEU to progress over the next few years. They are also considering how to address gaps in low-enriched uranium and high-assay low-enriched uranium.
Q:What is the outlook for the Medical segment, and any updates on Tc-99?
A:The Medical segment is experiencing strong growth across products like strontium, germanium, TheraSphere, and Actinium-225. Tc-99 is progressing, but there is no forecasted revenue for it in 2026.
Q:What is the company's involvement in the SHIELD contract for Golden Dome?
A:The company is a Golden Dome contract recipient, focusing on broad infrastructure scope. They see potential opportunities in microreactors and small modular reactors for distributed power.
Q:What is the growth outlook for Kinectrics' power and grid infrastructure business?
A:Kinectrics' power and grid infrastructure business accounts for about 10% of its portfolio and is growing faster than other parts, particularly in cable testing for wind power in Europe.
Q:What is the company's CapEx outlook, and could it exceed 6% of sales?
A:CapEx could exceed 6% of sales, potentially reaching around 7%, if the company decides to build a greenfield facility for large-scale manufacturing components in the U.S.
Q:What is the company's perspective on delivery risk for nuclear projects?
A:The company acknowledges delivery risk for nuclear projects, particularly on the engineering, procurement, and construction side. They believe the industry needs to address this risk through talent injection, AI, and robotic construction.
Q:What is the status of the small modular reactor project at Darlington?
A:The project is reasonably on track, with the first reactor pressure vessel delivery expected next year. Orders for following units are anticipated relatively shortly.
Q:What stood out in the Department of War and Department of Energy budgets?
A:The budgets showed good support for Pele, defense fuels, and long lead procurement for additional Columbia-class submarines, indicating a robust naval nuclear propulsion program.
Q:What is the company's involvement in the Korean nuclear submarine initiative?
A:The company sees potential opportunities in supplying fuel for Korean nuclear submarines, but the initiative is in very early stages.
Q:What are the company's M&A priorities?
A:The company is focused on expanding capacity and capabilities within the full lifecycle of nuclear to support customers end-to-end.
Q:How quickly can the company pivot PCG's capacity to more commercial use, and what is the potential margin uplift?
A:The company can immediately move some outsourced work in-house to capture profits, but fully ramping up capacity will take a few years. Margins, currently in low double digits, could increase slightly with scale and in-sourcing.
Q:What is the company's involvement in AUKUS?
A:The company is building infrastructure to support AUKUS and sees good funding support, but there are no new disclosures at this point.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the timeline for awards related to the Japan $40 billion GE Hitachi project, stating that there are hurdles to clear. Additionally, they did not provide detailed insight into the delivery schedule for the small modular reactor project at Darlington, only mentioning that it is reasonably on track.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Canada
Commercial
Government
HPDU contract
Kinectrics expectation
PCG acquisition
SMR
Tennessee engagement
backlog
capability
capacity BWXT
cash flow
class
component
construction
contribution Kinectrics
contribution PCG
defense fuel
digit
enrichment
entry point
expectation teen
facility
investment
manufacturing capacity
margin
market
program
project
rate
reactor
segment
teen power
throughput
BWXT Transcript
BWX Technologies, Inc. (BWXT) Q1 2026 Earnings Call Transcript
Unknown5-5
The earnings call summary presents a mixed picture. While there are positive elements such as strong growth in the Medical segment and unique positioning in TRISO fuel production, there are concerns about delivery risks in nuclear projects and high CapEx. The Q&A section highlights uncertainties, such as unclear timelines for key projects and potential delivery risks, which could weigh on investor sentiment. Without a clear market cap, it's challenging to gauge the exact impact, but the presence of both positive and negative factors suggests a neutral stock price movement.
BWX Technologies, Inc. (BWXT) Q4 2025 Earnings Call Transcript
Positive2-23
The earnings call highlighted strong financial performance with record revenue and significant growth in operating income, net income, and free cash flow. The strategic outlook for 2026 is optimistic, with expectations of continued growth in key segments like government and commercial operations. While there are risks associated with forward-looking statements and reliance on non-GAAP measures, the overall sentiment is positive. The absence of shareholder return plans does not significantly impact the positive outlook due to strong financial metrics and optimistic guidance.
BWX Technologies, Inc. (BWXT) Q3 2025 Earnings Call Transcript
Positive11-3
The earnings call summary and Q&A session indicate strong financial metrics with raised guidance across revenue, EBITDA, EPS, and free cash flow. The Kinectrics acquisition and government/commercial operations show promising growth. Despite some risks, such as lower initial margins and delayed Project Pele delivery, the market strategy with SMRs and medical segment growth is optimistic. The positive sentiment is further supported by the strategic partnerships and opportunities in nuclear energy. Overall, the outlook suggests a positive stock price movement, likely in the 2% to 8% range.
BWX Technologies, Inc. (BWXT) Q2 2025 Earnings Call Transcript
Positive8-4
The earnings call summary shows strong strategic developments, including backlog growth, new contracts, and expansion plans, indicating positive future prospects. The Q&A section reveals proactive measures addressing bottlenecks and strategic partnerships, with analysts showing interest in nuclear and microreactor markets. Despite some uncertainties, the guidance remains optimistic, with a focus on revenue growth and margin expectations. The overall sentiment leans towards positive, suggesting a stock price increase over the next two weeks.
BWXT Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
